A composition that is useful for disinfecting surfaces, instruments, or equipment that may comprise an oxidizer precursor, a pH adjusting agent, an acetylating agent, a chelating agent, and a quaternary ammonium salt is described. The composition may be dispensed in a variety of ways, for example, such as a sprayed solution, a fog, or a foam.

A composition that is useful for disinfecting surfaces, instruments, or equipment that may comprise an oxidizer precursor, a pH adjusting agent, an acetylating agent, a chelating agent, and a quaternary ammonium salt is described. The composition may be dispensed in a variety of ways, for example, such as a sprayed solution, a fog, or a foam.

Disclosed herein are disinfecting caps that can be used to cover and disinfect both a male medical connector and needleless injection site when not in use or when disconnected from each other. The caps contain a disinfecting agent.

The present disclosure relates to methods for producing large scale nanostructured material comprising carbon nanotubes. Therefore, there is disclosed a method for making nanostructured materials comprising depositing carbon nanotubes onto at least one substrate via a deposition station, wherein depositing comprises transporting molecules to the substrate from a deposition fluid, such as liquid or gas. By using a substrate that is permeable to the carrier fluid, and allowing the carrier fluid to flow through the substrate by differential pressure filtration, a nanostructured material can be formed on the substrate, which may be removed, or may act as a part of the final component.

Antiviral biomimetic polymers (ABPs) are disclosed that can be used to prevent and/or treat viral disease. The ABPs are discovered by a process involving high-throughput screening of polymer libraries using disease-relevant bioactive molecules as target molecules. ABPs can be nanoscale (termed nanoABPs) or larger. Methods are described for the preparation and use of ABPs as prophylactics and therapeutics (in vivo) and as preventative agents, for example, in personal protective equipment (ex vivo). ABPs can be used to prevent and treat viral diseases including those caused by Filoviridae.

Antiviral biomimetic polymers (ABPs) are disclosed that can be used to prevent and/or treat viral disease. The ABPs are discovered by a process involving high-throughput screening of polymer libraries using disease-relevant bioactive molecules as target molecules. ABPs can be nanoscale (termed nanoABPs) or larger. Methods are described for the preparation and use of ABPs as prophylactics and therapeutics (in vivo) and as preventative agents, for example, in personal protective equipment (ex vivo). ABPs can be used to prevent and treat viral diseases including those caused by Filoviridae.

The present invention relates to a water-soluble effervescent solid perfume comprising a high content of fragrance which does not include organic solvents such as surfactants, preservatives, and alcohols. In addition, additional components may be carried for cleaning and sterilizing effects, and the effects of fragrance, cleaning, sterilization, and the like may be increased by impartation of an effervescent property. Furthermore, there is no generation of residual by-products after effervescent, and may be processed into a solid formulation, thereby improving stability and improving portability and convenience of use.

The present invention relates to a water-soluble effervescent solid perfume comprising a high content of fragrance which does not include organic solvents such as surfactants, preservatives, and alcohols. In addition, additional components may be carried for cleaning and sterilizing effects, and the effects of fragrance, cleaning, sterilization, and the like may be increased by impartation of an effervescent property. Furthermore, there is no generation of residual by-products after effervescent, and may be processed into a solid formulation, thereby improving stability and improving portability and convenience of use.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

Disclosed herein are articles (e.g., wearable articles, such as gloves and masks) comprising an antimicrobial material, and methods of manufacture thereof. In various embodiments, the antimicrobial material comprises dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium, or a salt thereof. In some embodiments, the antimicrobial article (e.g., a wearable article, such as a glove or mask) may have antiviral properties against coronavirus, such as SARS-CoV-2.